Lundbeck
HLUN-B.CO
#2589
Rank
C$9.79 B
Marketcap
C$9.87
Share price
0.74%
Change (1 day)
-0.53%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2026 (TTM): C$1.06

According to Lundbeck's latest financial reports the company's current EPS (TTM) is C$1.09. In 2025 the company made an earnings per share (EPS) of C$0.72 an increase over its 2024 EPS that were of C$0.63.

EPS history for Lundbeck from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$1.0646.46%
2025C$0.7214.5%
2024C$0.6329.29%
2023C$0.4923.09%
2022C$0.4037.26%
2021C$0.29-84.61%
2020C$1.88-24.61%
2019C$2.49-42.06%
2018C$4.3040.7%
2017C$3.06146.26%
2016C$1.24-120.48%
2015C-$6.063231.32%
2014C-$0.18-115.78%
2013C$1.15-23.36%
2012C$1.50-48.01%
2011C$2.89-9.68%
2010C$3.2013.72%
2009C$2.8124.32%
2008C$2.26-6.05%
2007C$2.4181.77%
2006C$1.33-16.76%
2005C$1.59-17.58%
2004C$1.93